Dr. Sanjeev Chaudhary
He is a renowned interventional cardiologist with an experience of over 12 years. His last assignment was as senior interventional cardiologist at Paras hospitals Gurgaon where he worked for more than 5 years. He has a vast experience in performing coronary angioplasty and has performed over five thousand interventional procedures. He has a keen interest in clinical research and is principal investigator in many clinical research studies. He has contributed maximum number of cases all over India in multinational TAO study. He has a special interest in primary angioplasty ( angioplasty in acute heart attack) and coronary artery disease in diabetics.
- Fellow of DNB, Cardiology Batra Hospital & Research Center, New Delhi 2002 – 2005
- Consultant, Cardiology, Fortis Hospital Noida 2005 - 2006
- Consultant, Cardiology, Escorts Heart Institute & Research Center, Delhi, 2006-2008
- Senior Consultant, Cardiology, Paras Hospitals, Gurgaon, 2008-2013
- Director, Cardiology, Fortis Memorial Research Institute,Gurgaon, 2013 - Present
- Lifetime Member of Association of Physicians of India and
- Member of Indian Society of Echocardiography
- Life Membership Cardiology Society of India.
- Fellow of European Society of Cardiology.
- He has special interest in coronary angioplasty and coronary angiography
- Coronary disease in the diabetics.
- Complex coronary interventions.
- Awarded double gold medalist in PGIMS, Rohtak
- TAO STUDY Principal Investigator : Randomized double blind triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin & eptifibatide, in patients with Unstable angina Non ST segment Elevation Myocardial Infarction scheduled to undergo an early.
- ELIXA STUDY Principal Investigator : A randomized, double blind, placebo group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome
- EPICOR ASIA Principal Investigator : Long term follow up of antithrombotic management patterns in acute coronary syndrome patients in Asia.
- ODYSSEY STUDY: Principal Investigator